United States · Biotechnology startup
United States · Amagma Therapeutics
Amagma is a biotechnology company that develops and commercializes antibody therapeutics for the treatment of inflammatory diseases.
Funding reportedLast round: Venture (Round not Specified)
What company datasets say Amagma Therapeutics raised
Funding, as reported
Reported in all$2.3Min dollars
Last roundVenture (Round not Specified)
Last round size$2.3M
Last round dateJun 2022
Investors listed2
The company, in detail
What they build
Built with from their website
Android
- Sector
- Biotechnology
- Region
- Massachusetts
- Revenue
- $350K a year, as listed
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Amagma Therapeutics in front of investors. Or tell us what we have wrong.